Dyslipidemia
📧 Sign up to get email alerts when something new happens for Dyslipidemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-07-24Clinical Trial Update: Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Hyperlipidemia or Mixed Dyslipidemia at Risk of Cardiovascular Events [Phase 3]
A Phase 3 randomized trial of bococizumab in adults with hyperlipidemia or mixed dyslipidemia at risk of cardiovascular events has completed…
-
CLINICAL_TRIALS trial_result · 2017-07-21Clinical Trial Update: Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Primary Hyperlipidemia or Mixed Dyslipidemia At Risk Of Cardiovascular Events [Phase 3]
Phase 3 randomized trial of bococizumab in people with primary hyperlipidemia or mixed dyslipidemia at risk for cardiovascular events comple…
-
CLINICAL_TRIALS trial_result · 2017-07-21Clinical Trial Update: Effect of Polyvitaminics (Pyridoxine Hydrochloride, Folic Acid and Cyanocobalamin) in the Concentration of Homocysteine and Lipid Profile in Postmenopausal Women: a Randomized Controlled, Double-blind Clinical Trial [Phase 4]
A randomized, double-blind Phase 4 trial evaluating the effect of a vitamin combination (pyridoxine, folic acid, and cyanocobalamin) on homo…
-
CLINICAL_TRIALS trial_result · 2017-07-13Clinical Trial Update: Study to Investigate the Safety/Tolerability and Pharmacokinetics/Pharmacodynamics of CKD-519 [Phase 1]
Phase 1 trial update for CKD-519 in dyslipidemia indicates the study has completed. The snippet does not report results beyond safety/tolera…
-
CLINICAL_TRIALS trial_result · 2017-07-07Clinical Trial Update: Study to Investigate the Safety/Tolerability and Pharmacokinetics/Pharmacodynamics of CKD-519 [Phase 1]
Phase 1 study evaluating safety, tolerability and pharmacokinetics/pharmacodynamics of CKD-519 in dyslipidemia; the trial has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-06-22Clinical Trial Update: The Effects of Dietary Supplement of Coenzyme Q10（CoQ10） on Dyslipidemia [Phase 3]
A completed Phase 3 trial evaluated the effects of a Coenzyme Q10 dietary supplement on dyslipidemia.
-
CLINICAL_TRIALS trial_result · 2017-06-19Clinical Trial Update: The Cork and Kerry Diabetes and Heart Disease Study (Phase II) Mitchelstown Cohort
Phase II Cork and Kerry Diabetes and Heart Disease Study (Mitchelstown Cohort) has completed; the update pertains to cardiovascular disease …
-
CLINICAL_TRIALS trial_result · 2017-06-05Clinical Trial Update: Repeat Dose Food Effect Study of GSK256073F in Healthy Adult Subjects [Phase 1]
A Phase 1 repeat-dose food-effect study of the investigational compound GSK256073F in healthy adult subjects has completed.
-
CLINICAL_TRIALS trial_result · 2017-06-01Clinical Trial Update: A Study of the Safety and Efficacy of Anacetrapib (MK-0859) When Added to Ongoing Statin Therapy in Japanese Participants With Dyslipidemia (MK-0859-051 AM1) [Phase 3]
Phase 3 study evaluating safety and efficacy of adding Anacetrapib to ongoing statin therapy in Japanese participants with dyslipidemia; the…
-
CLINICAL_TRIALS trial_result · 2017-06-01Clinical Trial Update: Effects of Exercise on Fructose-induced Postprandial Lipemia [NA]
This completed clinical trial evaluated whether exercise modulates fructose-induced postprandial lipemia in adults with a sedentary lifestyl…
-
CLINICAL_TRIALS trial_result · 2017-05-30Clinical Trial Update: The Metabolic Effects of Consuming Sugar-Sweetened Beverages for Two Weeks [NA]
This completed clinical trial assessed the metabolic effects of consuming sugar-sweetened beverages for two weeks in adults with metabolic s…
-
CLINICAL_TRIALS trial_result · 2017-05-30Clinical Trial Update: Effects of Consuming Sugar-Sweetened Beverages With Meals for 10 Weeks [NA]
A completed clinical trial evaluated the effects of consuming sugar-sweetened beverages with meals for 10 weeks in individuals with metaboli…
-
CLINICAL_TRIALS trial_result · 2017-05-30Clinical Trial Update: GW501516 In Subjects Who Have Low Level Of High-Density Lipoprotein Cholesterol [Phase 2]
Phase 2 trial update for GW501516 in individuals with low HDL cholesterol has completed.
-
CLINICAL_TRIALS trial_result · 2017-05-17Clinical Trial Update: Fluvastatin in Adults With Dislipidemia With History of Muscle Problems [Phase 4]
This Phase 4 trial evaluating fluvastatin in adults with dyslipidemia and a history of muscle problems has completed.
-
CLINICAL_TRIALS trial_result · 2017-04-26Clinical Trial Update: Study Comparing Fish Oil and Krill Oil [NA]
The Tufts University-sponsored trial comparing fish oil with krill oil for inflammation and dyslipidemia was terminated.
-
CLINICAL_TRIALS trial_result · 2017-04-12Clinical Trial Update: Effect of Weight Management Programs on Cardiometabolic Risk Profile in Overweight Women [Phase 3]
A Phase 3 clinical trial evaluating the impact of weight management programs on cardiometabolic risk in overweight women. The study status i…
-
CLINICAL_TRIALS trial_result · 2017-03-28Clinical Trial Update: Evaluation of Combination Cholesterol Treatments in Patients With High Cholesterol. [Phase 4]
Phase 4 clinical trial evaluating combination cholesterol therapies in patients with high cholesterol; status is completed.
-
CLINICAL_TRIALS trial_result · 2017-03-01Clinical Trial Update: Reducing the Overall Risk Level in Patients Suffering From Metabolic Syndrome [Phase 4]
The document reports a Phase 4 clinical trial update from Novartis focused on reducing overall cardiovascular risk in patients with metaboli…
-
CLINICAL_TRIALS trial_result · 2017-02-24Clinical Trial Update: Efficacy of Fluvastatin and Fenofibrate in Comparison to Simvastatin and Ezetimibe in Patients With Metabolic Syndrome [Phase 4]
Phase 4 trial updating on the efficacy of a fluvastatin plus fenofibrate regimen versus a simvastatin plus ezetimibe regimen in patients wit…
-
CLINICAL_TRIALS trial_result · 2017-02-23Clinical Trial Update: Trial to Evaluate the Efficacy of Fluvastatin on Certain Markers [Phase 4]
Phase 4 trial evaluating the efficacy of fluvastatin on certain markers in dyslipidemia has completed.
-
CLINICAL_TRIALS trial_result · 2017-02-17Clinical Trial Update: An Investigational Drug Study Evaluating a Novel Approach to Treat Dyslipidemia (0524A-032) [Phase 2]
A Phase 2 investigational drug study for dyslipidemia has completed. The snippet does not provide efficacy results.
-
CLINICAL_TRIALS trial_result · 2017-02-13Clinical Trial Update: A Randomized, Double-blind, Multicenter, Phase III Study to Evaluate the Efficacy and Safety of Combination of Fimasartan/Rosuvastatin in Comparison to Each Component Administered Alone in Patients With Essential Hypertension and Dyslipidemia [Phase 3]
Phase III randomized, double-blind, multicenter trial comparing the combination of fimasartan and rosuvastatin to each component alone in pa…
-
CLINICAL_TRIALS trial_result · 2017-01-23Clinical Trial Update: Efficacy and Tolerability of the Nutraceutical Formulation Coleosoma in Dyslipidemic Subjects [Phase 2]
Phase 2 trial assessing the efficacy and tolerability of the nutraceutical Coleosoma in dyslipidemia subjects has been completed.
-
CLINICAL_TRIALS trial_result · 2017-01-19Clinical Trial Update: Dietary Intake of Alpha-linolenic Acid in Elderly [NA]
Completed trial (NCT03025620) evaluating the effects of dietary alpha-linolenic acid intake in older adults on cardiovascular, inflammatory,…
-
CLINICAL_TRIALS trial_result · 2016-12-13Clinical Trial Update: A Study to Evaluate Efficacy and Safety of Extended-Release Niacin + Laropiprant + Simvastatin in Participants With Primary Hypercholesterolemia or Mixed Dyslipidemia (MK-0524B-118) [Phase 3]
Phase 3 trial evaluating extended-release niacin combined with laropiprant and simvastatin in primary hypercholesterolemia or mixed dyslipid…